JOHN C. MORRISON, M.D.; HENRY FOSTER, M.D.
This content is PDF only. Please click on the PDF icon to access.
Four consensus groups met in Bethesda, Maryland, on 23 and 24 April 1979 to consider whether there is sufficient evidence about prophylactic transfusion therapy to advocate its use for treatment of pregnant patients with sickle-cell disease. The work groups focused on four subject areas: need for further research, clinical research approaches, perinatal considerations, and sociomedical issues. Each group developed conclusions on its own subject.
Further research in transfusion therapy for pregnant patients with sickle-cell disease is needed, but the question must be approached systematically.
In transfusion therapy, pregnant patients with sickle-cell disease are
Learn more about subscription options.
Register Now for a free account.
MORRISON JC, FOSTER H. Transfusion Therapy in Pregnant Patients with Sickle-Cell Disease: A National Institutes of Health Consensus Development Conference. Ann Intern Med. 1979;91:122–123. doi: 10.7326/0003-4819-91-1-122
Download citation file:
Published: Ann Intern Med. 1979;91(1):122-123.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only